{"version":"1.0","type":"link","title":"Characteristics and outcomes of patients with HCC treated with atezolizumab/bevacizumab, stratified by second line therapy.","author_name":"Singal AG 외","author_url":"https://prs-insight.online/author/Singal%20AG","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/110377","thumbnail_width":1200,"thumbnail_height":630}